Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
424.4 USD | -1.29% | +3.95% | +4.81% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 92 M€ | +0.06% | - | |
0.48% | 1,448 M€ | -.--% | - | |
0.48% | 219 M€ | +17.17% | - | |
0.47% | 330 M€ | -.--% | ||
0.44% | 36 M€ | +22.19% | ||
0.42% | 9 M€ | +8.59% | ||
0.38% | 25 M€ | +3.50% | - | |
0.35% | 1,174 M€ | +23.54% | ||
0.35% | 655 M€ | -.--% | - | |
0.35% | 273 M€ | -.--% | ||
0.35% | 375 M€ | +8.00% | ||
0.35% | 368 M€ | +19.00% | - | |
0.34% | 276 M€ | +11.40% | - | |
0.32% | 559 M€ | +14.30% | ||
0.32% | 1,848 M€ | +18.39% | - | |
0.32% | 1 M€ | +0.04% | ||
0.32% | 2,383 M€ | +12.59% | ||
0.30% | 26 M€ | +19.98% | - | |
0.28% | 50 M€ | +9.13% | ||
0.28% | 8 M€ | +5.74% | - | |
0.28% | 744 M€ | +8.55% | ||
0.25% | 1 M€ | -.--% | ||
0.25% | 36 M€ | +2.97% | - | |
0.23% | 6 M€ | +17.98% | - | |
0.23% | 121 M€ | +6.52% | - | |
0.22% | 17 M€ | +3.81% | - | |
0.22% | 34 M€ | +11.62% | - | |
0.22% | 35 M€ | +8.00% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.81% | 111B | |
+10.87% | 105B | |
-12.25% | 22.34B | |
-3.14% | 21.93B | |
-5.85% | 18.59B | |
-36.52% | 18.12B | |
-9.72% | 16.96B | |
+2.95% | 13.7B | |
+38.07% | 12.45B | |
+297.64% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated